Name: UMIN ID:
Unique ID issued by UMIN | UMIN000003027 |
---|---|
Receipt number | R000003671 |
Scientific Title | Phase II clinical trial of personalized peptide vaccination for Renal cell carcinoma patients |
Date of disclosure of the study information | 2010/01/13 |
Last modified on | 2019/10/30 13:25:37 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2010/01/13 18:34:42 | ||
2 | Update | 2010/01/25 11:02:13 | Key inclusion criteria |
|
3 | Update | 2010/07/16 14:30:35 | Organization1 Tel1 Email1 |
|
4 | Update | 2014/07/10 14:56:53 | TEL Institute Institute Organization Organization Nationality of Funding Organization Nationality of Funding Organization Post marketing survey by drug manufacture etc., specified by Japanese law. |
|
5 | Update | 2014/07/14 14:16:31 | Category of Funding Organization |
|
6 | Update | 2014/12/12 11:56:57 | Key secondary outcomes |
|
7 | Update | 2014/12/12 11:58:22 | Interventions/Control_1 Key inclusion criteria Key inclusion criteria |
|
8 | Update | 2019/01/07 10:53:20 | Recruitment status |
|
9 | Update | 2019/10/30 13:25:37 | Recruitment status Date of IRB Last follow-up date |